EndoSonics of Rancho Cordova, CA, announced this month an agreement with Jomed of Helsingborg, Sweden, to develop an intravascular ultrasound-guided stent delivery system together. The new system will integrate EndoSonics’ electronic imaging
EndoSonics of Rancho Cordova, CA, announced this month an agreement with Jomed of Helsingborg, Sweden, to develop an intravascular ultrasound-guided stent delivery system together. The new system will integrate EndoSonics electronic imaging catheter with Jomeds stent and balloon devices. The two firms hope their combined product will decrease post-angioplasty complications and streamline interventional procedures. Jomed anticipates marketing the device in early 1999, pending CE Mark approval.
In other EndoSonics news, the company announced that it has agreed to a five-year hiatus in its intellectual property claim litigation with Intravascular Research of the U.K. The temporary truce includes closing a Delaware lawsuit between the companies involving patent infringement disputes.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.